Jacobio Pharmaceuticals Schedules 24 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results
Bulletin Express
Aug 12
Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharmaceuticals) has announced that its board of directors will convene on 24 August 2026. The primary agenda includes reviewing and approving the interim financial results for the six months ended 30 June 2026 and authorising their publication. Additional routine corporate matters may also be addressed during the session.
The board is chaired by Dr. Yinxiang Wang, who serves as an executive director alongside Ms. Xiaojie Wang and Ms. Yunyan Hu. Dr. Te-li Chen holds the position of non-executive director, while Dr. Ruilin Song, Dr. Bai Lu and Dr. Ge Wu act as independent non-executive directors.
The meeting notice was released in Hong Kong on 12 August 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.